SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-23-011384
Filing Date
2023-04-12
Accepted
2023-04-12 16:01:05
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 s-3shelf2023.htm S-3 271042
2 EX-FILING FEES ex-107feetablesx3xapril2023.htm EX-FILING FEES 30896
3 EX-4.17 ex-417formofindenturesx3xa.htm EX-4.17 298171
4 EX-5.1 ex-51legalopinionconsentsx.htm EX-5.1 29605
5 EX-23.1 ex-231eyconsentsx3xapril20.htm EX-23.1 2491
6 GRAPHIC avalo-logoxblk1a.jpg GRAPHIC 99614
  Complete submission text file 0001628280-23-011384.txt   770470
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271225 | Film No.: 23815643
SIC: 2834 Pharmaceutical Preparations